Organization: Health Canada
Year: 2025
Month: January
Request Number: A-2024-000385
Request Summary: Adverse Drug Reaction (ADR) for Alunbrig. Report number: E2B_07054884. ADR for Amphetamine aspartate monohydrate/ amphetamine sulfate/ dextroamphetamine saccharate/ dextroamphetamine sulfate. Report number: E2B_07092490. ADRs for Mesalazine. Report numbers: E2B_07078275, E2B_07093426, E2B_07067311, E2B_07069546, 001084682, E2B_07090625. ADRs for VYVANSE. Report numbers: 001085216, E2B_07102745.
Disposition: Disclosed in part
Number of pages: 400